Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4715

1.

Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy.

Zhu D, Shen H, Tan S, Hu Z, Wang L, Yu L, Tian X, Ding W, Ren C, Gao C, Cheng J, Deng M, Liu R, Hu J, Xi L, Wu P, Zhang Z, Ma D, Wang H.

Mol Ther. 2018 Jul 25. pii: S1525-0016(18)30347-2. doi: 10.1016/j.ymthe.2018.07.019. [Epub ahead of print]

PMID:
30241742
2.

AAV Immunogenicity: A Matter of Sensitivity.

Mingozzi F.

Mol Ther. 2018 Sep 18. pii: S1525-0016(18)30442-8. doi: 10.1016/j.ymthe.2018.09.001. [Epub ahead of print] No abstract available.

PMID:
30241741
3.

Sorting Out the Best: Enriching Hematopoietic Stem Cells for Gene Therapy and Editing.

Radtke S, Humbert O, Kiem HP.

Mol Ther. 2018 Sep 13. pii: S1525-0016(18)30435-0. doi: 10.1016/j.ymthe.2018.08.025. [Epub ahead of print] No abstract available.

PMID:
30220614
4.

Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.

Bosco A, Anderson SR, Breen KT, Romero CO, Steele MR, Chiodo VA, Boye SL, Hauswirth WW, Tomlinson S, Vetter ML.

Mol Ther. 2018 Aug 24. pii: S1525-0016(18)30420-9. doi: 10.1016/j.ymthe.2018.08.017. [Epub ahead of print]

PMID:
30217731
5.

Molecular Recalibration of PD-1+ Antigen-Specific T Cells from Blood and Liver.

Otano I, Escors D, Schurich A, Singh H, Robertson F, Davidson BR, Fusai G, Vargas FA, Tan ZMD, Aw JYJ, Hansi N, Kennedy PTF, Xue SA, Stauss HJ, Bertoletti A, Pavesi A, Maini MK.

Mol Ther. 2018 Aug 16. pii: S1525-0016(18)30390-3. doi: 10.1016/j.ymthe.2018.08.013. [Epub ahead of print]

6.

Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.

Xie S, Yu X, Li Y, Ma H, Fan S, Chen W, Pan G, Wang W, Zhang H, Li J, Lin Z.

Mol Ther. 2018 Aug 24. pii: S1525-0016(18)30421-0. doi: 10.1016/j.ymthe.2018.08.018. [Epub ahead of print]

PMID:
30217729
7.

Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells.

Yoshida S, Miyagawa S, Fukushima S, Kawamura T, Kashiyama N, Ohashi F, Toyofuku T, Toda K, Sawa Y.

Mol Ther. 2018 Aug 16. pii: S1525-0016(18)30383-6. doi: 10.1016/j.ymthe.2018.08.012. [Epub ahead of print]

8.

Nasal Spray to the Rescue of Neurons in Stroke.

Alzheimer C.

Mol Ther. 2018 Sep 11. pii: S1525-0016(18)30434-9. doi: 10.1016/j.ymthe.2018.08.024. [Epub ahead of print] No abstract available.

PMID:
30217727
9.

Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.

Cukras C, Wiley HE, Jeffrey BG, Sen HN, Turriff A, Zeng Y, Vijayasarathy C, Marangoni D, Ziccardi L, Kjellstrom S, Park TK, Hiriyanna S, Wright JF, Colosi P, Wu Z, Bush RA, Wei LL, Sieving PA.

Mol Ther. 2018 Sep 5;26(9):2282-2294. doi: 10.1016/j.ymthe.2018.05.025. Epub 2018 Jul 7.

PMID:
30196853
10.

PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients.

Capilla-González V, López-Beas J, Escacena N, Aguilera Y, de la Cuesta A, Ruiz-Salmerón R, Martín F, Hmadcha A, Soria B.

Mol Ther. 2018 Aug 16. pii: S1525-0016(18)30382-4. doi: 10.1016/j.ymthe.2018.08.011. [Epub ahead of print]

PMID:
30195725
11.

CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo.

Duchêne BL, Cherif K, Iyombe-Engembe JP, Guyon A, Rousseau J, Ouellet DL, Barbeau X, Lague P, Tremblay JP.

Mol Ther. 2018 Aug 16. pii: S1525-0016(18)30381-2. doi: 10.1016/j.ymthe.2018.08.010. [Epub ahead of print]

PMID:
30195724
12.

Correction of the Marfan Syndrome Pathogenic FBN1 Mutation by Base Editing in Human Cells and Heterozygous Embryos.

Zeng Y, Li J, Li G, Huang S, Yu W, Zhang Y, Chen D, Chen J, Liu J, Huang X.

Mol Ther. 2018 Aug 14. pii: S1525-0016(18)30378-2. doi: 10.1016/j.ymthe.2018.08.007. [Epub ahead of print]

13.

Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit.

Sreetama SC, Chandra G, Van der Meulen JH, Ahmad MM, Suzuki P, Bhuvanendran S, Nagaraju K, Hoffman EP, Jaiswal JK.

Mol Ther. 2018 Sep 5;26(9):2231-2242. doi: 10.1016/j.ymthe.2018.07.021. Epub 2018 Aug 27.

14.

Transvascular Delivery of Hydrophobically Modified siRNAs: Gene Silencing in the Rat Brain upon Disruption of the Blood-Brain Barrier.

Godinho BMDC, Henninger N, Bouley J, Alterman JF, Haraszti RA, Gilbert JW, Sapp E, Coles AH, Biscans A, Nikan M, Echeverria D, DiFiglia M, Aronin N, Khvorova A.

Mol Ther. 2018 Aug 8. pii: S1525-0016(18)30376-9. doi: 10.1016/j.ymthe.2018.08.005. [Epub ahead of print]

PMID:
30143435
15.

Disruption of Chromosomal Architecture of cox2 Locus Sensitizes Lung Cancer Cells to Radiotherapy.

Sun Y, Dai H, Chen S, Zhang Y, Wu T, Cao X, Zhao G, Xu A, Wang J, Wu L.

Mol Ther. 2018 Aug 8. pii: S1525-0016(18)30373-3. doi: 10.1016/j.ymthe.2018.08.002. [Epub ahead of print]

16.

A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML.

John S, Chen H, Deng M, Gui X, Wu G, Chen W, Li Z, Zhang N, An Z, Zhang CC.

Mol Ther. 2018 Aug 7. pii: S1525-0016(18)30372-1. doi: 10.1016/j.ymthe.2018.08.001. [Epub ahead of print]

PMID:
30131301
17.

iPSC-Derived Cardiomyocytes Taken to Rescue Infarcted Heart Muscle in Coronary Heart Disease Patients.

Ylä-Herttuala S.

Mol Ther. 2018 Sep 5;26(9):2077. doi: 10.1016/j.ymthe.2018.08.006. Epub 2018 Aug 16. No abstract available.

PMID:
30122423
18.

CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.

Benati D, Miselli F, Cocchiarella F, Patrizi C, Carretero M, Baldassarri S, Ammendola V, Has C, Colloca S, Del Rio M, Larcher F, Recchia A.

Mol Ther. 2018 Aug 4. pii: S1525-0016(18)30371-X. doi: 10.1016/j.ymthe.2018.07.024. [Epub ahead of print]

PMID:
30122422
19.

Nanotechnology in Wound Care: One Step Closer to the Clinic.

Mozafari M.

Mol Ther. 2018 Sep 5;26(9):2085-2086. doi: 10.1016/j.ymthe.2018.08.008. Epub 2018 Aug 16. No abstract available.

PMID:
30121229
20.

T Cell Tumor Immunotherapy: Oncolysis Beats Lymphodepletion.

Barrett J.

Mol Ther. 2018 Sep 5;26(9):2083-2085. doi: 10.1016/j.ymthe.2018.08.004. Epub 2018 Aug 14. No abstract available.

PMID:
30120060

Supplemental Content

Loading ...
Support Center